Arvinas, Inc. (ARVN) Tops Q3 EPS by 40c

Arvinas, Inc. (NASDAQ: ARVN) reported Q3 EPS of ($1.18), $0.40 better than the analyst estimate of ($1.58). Revenue for the quarter came in at $34.6 million versus the consensus estimate of $39.58 million.

For earnings history and earnings-related data on Arvinas, Inc. (ARVN) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Oppenheimer Starts Collegium Pharmaceutical (COLL) at Outperform
• Oppenheimer Starts Teva Pharma (TEVA) at Outperform